Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07746154 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Down Electroencephalography (EEG) Neurofeedback for Alcohol Use Disorder: Feasibility Trial

Study acronym: Neurofeedback
StatusNot Yet Recruiting
PhaseNot applicable
Started2026-12-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 1, 2027 → Dec 1, 2027
See other at-risk trials from Brigham and Women's Hospital

Amendment history

2026-10-02
notable
Primary completion pushed: 2027-07-01 → 2027-12-01
This pilot study is testing a short brain training program called neurofeedback in adults with alcohol use disorder. Participants will complete three sessions over about one week. The goal is to learn if this approach is easy to complete, well tolerated, and acceptable to participants. We will also explore whether it is associated with changes in alcohol cravings and drinking.
Trial Details
NCT Number NCT07746154
Lead Sponsor Brigham and Women's Hospital
Conditions Alcohol Use Disorder (AUD)
Enrollment 10 participants
Start Date 2026-12-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-10-01